Timothy Pond

454 total citations
19 papers, 334 citations indexed

About

Timothy Pond is a scholar working on Epidemiology, Pathology and Forensic Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Timothy Pond has authored 19 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 5 papers in Pathology and Forensic Medicine and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Timothy Pond's work include Substance Abuse Treatment and Outcomes (6 papers), Alcohol Consumption and Health Effects (5 papers) and Gambling Behavior and Treatments (4 papers). Timothy Pond is often cited by papers focused on Substance Abuse Treatment and Outcomes (6 papers), Alcohol Consumption and Health Effects (5 papers) and Gambling Behavior and Treatments (4 papers). Timothy Pond collaborates with scholars based in United States and Czechia. Timothy Pond's co-authors include Henry R. Kranzler, Richard Feinn, Jonathan Covault, Albert J. Arias, Cheryl Oncken, Joel Gelernter, Kyle M. Kampman, Howard Tennen, Stephen Armeli and Reagan R. Wetherill and has published in prestigious journals such as American Journal of Psychiatry, International Journal of Molecular Sciences and Neuropsychopharmacology.

In The Last Decade

Timothy Pond

18 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Timothy Pond United States	9	161	146	84	49	47	19	334
Xin Qun Wang United States	5	216 1.3×	156 1.1×	101 1.2×	58 1.2×	75 1.6×	8	393
ReJoyce Green United States	12	223 1.4×	169 1.2×	81 1.0×	25 0.5×	70 1.5×	39	450
Nassima Ait‐Daoud Tiouririne United States	7	182 1.1×	145 1.0×	94 1.1×	54 1.1×	48 1.0×	10	389
Katrin Ramskogler Austria	11	172 1.1×	86 0.6×	143 1.7×	51 1.0×	34 0.7×	18	410
R. Stracke Germany	2	178 1.1×	131 0.9×	91 1.1×	40 0.8×	40 0.9×	5	295
Monte J. Phillips United States	12	99 0.6×	119 0.8×	68 0.8×	41 0.8×	51 1.1×	16	424
Tomohiro Miyakawa Japan	10	79 0.5×	171 1.2×	44 0.5×	56 1.1×	53 1.1×	14	405
WW Fleischhacker Austria	4	125 0.8×	110 0.8×	59 0.7×	92 1.9×	71 1.5×	7	321
Mila Ferri Italy	8	114 0.7×	203 1.4×	58 0.7×	54 1.1×	109 2.3×	11	449
Pekka Heinälä Finland	7	174 1.1×	119 0.8×	115 1.4×	31 0.6×	30 0.6×	10	353

Countries citing papers authored by Timothy Pond

Since Specialization

Citations

This map shows the geographic impact of Timothy Pond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy Pond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy Pond more than expected).

Fields of papers citing papers by Timothy Pond

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy Pond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy Pond. The network helps show where Timothy Pond may publish in the future.

Co-authorship network of co-authors of Timothy Pond

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy Pond. A scholar is included among the top collaborators of Timothy Pond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy Pond. Timothy Pond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Pond, Timothy, et al.. (2026). Pharmacokinetic effects of a single dose nutritional ketone ester supplement on brain glucose and ketone metabolism in alcohol use disorder. Psychiatry Research Neuroimaging. 357. 112154–112154.

Li, Xinyi, Zhenhao Shi, Timothy Pond, et al.. (2024). Ketone Supplementation Dampens Subjective and Objective Responses to Alcohol: Evidence From a Preclinical Rat Study and a Randomized, Cross-Over Trial in Healthy Volunteers. The International Journal of Neuropsychopharmacology. 27(2). 4 indexed citations

Votaw, Victoria R., Katie Witkiewitz, M. Lee Van Horn, et al.. (2023). An intensive longitudinal examination of topiramate treatment for alcohol use disorder: a secondary analysis of data from a randomized controlled trial. Addiction. 118(6). 1040–1052. 4 indexed citations

Li, Xinyi, Thanh D. Nguyen, Yi Wang, et al.. (2023). Peripheral and Central Iron Measures in Alcohol Use Disorder and Aging: A Quantitative Susceptibility Mapping Pilot Study. International Journal of Molecular Sciences. 24(5). 4461–4461. 3 indexed citations

Kranzler, Henry R., Richard Feinn, Timothy Pond, et al.. (2022). Post‐treatment effects of topiramate on alcohol‐related outcomes: A combined analysis of two placebo‐controlled trials. Addiction Biology. 27(2). e13130–e13130. 3 indexed citations

Seneviratne, Chamindi, David A. Gorelick, Kevin G. Lynch, et al.. (2022). A randomized, double‐blind, placebo‐controlled, pharmacogenetic study of ondansetron for treating alcohol use disorder. Alcoholism Clinical and Experimental Research. 46(10). 1900–1912. 9 indexed citations

Kranzler, Henry R., Paige E. Morris, Timothy Pond, et al.. (2021). Prospective randomized pharmacogenetic study of topiramate for treating alcohol use disorder. Neuropsychopharmacology. 46(8). 1407–1413. 21 indexed citations

Kranzler, Henry R., Emily E. Hartwell, Richard Feinn, et al.. (2021). Combined analysis of the moderating effect of a GRIK1 polymorphism on the effects of topiramate for treating alcohol use disorder. Drug and Alcohol Dependence. 225. 108762–108762. 8 indexed citations

Wetherill, Reagan R., Kanchana Jagannathan, Paige E. Morris, et al.. (2021). Effects of topiramate on neural responses to alcohol cues in treatment-seeking individuals with alcohol use disorder: preliminary findings from a randomized, placebo-controlled trial. Neuropsychopharmacology. 46(8). 1414–1420. 15 indexed citations

10.

Kranzler, Henry R., Paige E. Morris, Timothy Pond, et al.. (2021). Correction to: Prospective randomized pharmacogenetic study of topiramate for treating alcohol use disorder. Neuropsychopharmacology. 46(8). 1546–1546. 1 indexed citations

11.

Hartwell, Emily E., Richard Feinn, Katie Witkiewitz, Timothy Pond, & Henry R. Kranzler. (2021). World Health Organization risk drinking levels as a treatment outcome measure in topiramate trials. Alcoholism Clinical and Experimental Research. 45(8). 1664–1671. 9 indexed citations

12.

Vickers‐Smith, Rachel, et al.. (2017). Effects of Recent Alcohol Consumption Level on Neurocognitive Performance in HIV+ Individuals. Addictive Disorders & Their Treatment. 16(3). 95–107. 5 indexed citations

13.

Kranzler, Henry R., Stephen Armeli, Reagan R. Wetherill, et al.. (2014). Self‐efficacy mediates the effects of topiramate and GRIK1 genotype on drinking. Addiction Biology. 21(2). 450–459. 19 indexed citations

14.

Kranzler, Henry R., Jonathan Covault, Richard Feinn, et al.. (2014). Topiramate Treatment for Heavy Drinkers: Moderation by a GRIK1 Polymorphism. American Journal of Psychiatry. 171(4). 445–452. 143 indexed citations

15.

Kranzler, Henry R., Richard Feinn, Joel Gelernter, Timothy Pond, & Jonathan Covault. (2014). Topiramate’s reduction of body mass index in heavy drinkers: Lack of moderation by a GRIK1 polymorphism.. Experimental and Clinical Psychopharmacology. 22(5). 419–423. 7 indexed citations

16.

Kranzler, Henry R., Reagan R. Wetherill, Richard Feinn, et al.. (2014). Posttreatment Effects of Topiramate Treatment for Heavy Drinking. Alcoholism Clinical and Experimental Research. 38(12). 3017–3023. 19 indexed citations

17.

Gilbert, J, Robert A. Schnoll, Mary F. Morrison, et al.. (2014). Smoking and Cellular Telephone Use Among Pregnant Women Seeking Prenatal Care. Addictive Disorders & Their Treatment. 14(4). 203–210. 4 indexed citations

18.

Covault, Jonathan, Timothy Pond, Richard Feinn, et al.. (2014). Dutasteride reduces alcohol’s sedative effects in men in a human laboratory setting and reduces drinking in the natural environment. Psychopharmacology. 231(17). 3609–3618. 28 indexed citations

19.

Arias, Albert J., Jonathan Covault, Richard Feinn, et al.. (2013). A GABRA2 Variant Is Associated with Increased Stimulation and ‘High’ Following Alcohol Administration. Alcohol and Alcoholism. 49(1). 1–9. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact